PALX

Palomino Laboratories Inc.
—

Company Information

Company Name
Palomino Laboratories Inc.
CIK
CIK0001938569
Category
<br>Emerging growth company
Ticker: Exchange
PALX: OTC
Fiscal Year End
December 31
Owner Organization
04 Manufacturing
SIC
3674
SIC Description
Semiconductors & Related Devices
Ticker
PALX

SEC filing data through

Insider Sentiment

Last purchase
2026-04-20
Last sale
—
Shares purchased (TTM)
25,000
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
—
Institutional shares owned
—
Shares outstanding
—
Ownership
—

Earnings Market Reaction

Filing date
2026-08-05
Price on filing date
—
1-month reaction
22.85%
3-month reaction
…
Drift continued—
Faded / reversed—

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Related Party----00-0000-
Assets Current
Cash And Cash Equivalents At Carrying Value1978800000000
Prepaid Expense And Other Assets Current0000--0-----
Assets Current2078-00000000
Property Plant And Equipment Net10----------
Operating Lease Right Of Use Asset00----------
Deferred Costs-0----------
Other Assets00----------
Assets2178800000000
Accounts Payable And Accrued Liabilities Current----00000000
Notes Payable Current-----0-00000
Liabilities And Stockholders Equity
Convertible Notes Payable Current----0-------
Liabilities Current
Accounts Payable Current0000--0-----
Accrued Liabilities And Other Liabilities0001--------
Other Liabilities Current---0--0-----
Operating Lease Liability Current00----------
Liabilities Current000100000000
Other Liabilities Noncurrent------0-----
Operating Lease Liability Noncurrent00----------
Liabilities000100000000
Stockholders Equity
Common Stock Value000000000000
Additional Paid In Capital26111110---0-----
Retained Earnings Accumulated Deficit-6-4-3-2-0-0-0-0-0-0-0-0
Stockholders Equity21787-0-1-0-0-0-0-0-0
Liabilities And Stockholders Equity2178800000000
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized101010101010101010101010
Preferred Stock Shares Issued0000--0----0
Preferred Stock Shares Outstanding0000--0-----
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized30030030030050503005050505050
Common Stock Shares Issued2319191822522222
Shares Outstanding2319191822522222

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Palomino Laboratories Inc. (PALX) — SEC Financial Statements & Analysis

Palomino Laboratories Inc. (PALX) is a semiconductors & related devices company, incorporated in DE. Palomino Laboratories Inc. trades on OTC as: PALX. Palomino Laboratories Inc. (PALX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, On profitability, Palomino Laboratories Inc. posts a Return on Equity (ROE) of -51.45%, a Return on Assets (ROA) of -49.19%, and a Return on Invested Capital (ROIC) of -66.91%. Per share, it reports EPS of $-0.24, diluted EPS of $-0.24, free cash flow per share of $-0.22, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 878.70% year-over-year and EPS growth of 15.92% year-over-year. On the balance sheet, it maintains a current ratio of 53.12x, a quick ratio of 52.71x, working capital of $19.22M, a debt-to-equity ratio of 0.02x, a debt ratio of 0.02, an interest coverage ratio of -477.53x, free cash flow of $-4.70M (TTM), and net debt of $-19.44M. Figures sourced from SEC EDGAR.

EPS TTM
$-0.24
ROE TTM
-51.45%
ROA TTM
-49.19%
Debt To Equity
0.02x
Free Cash Flow TTM
$-4.70M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Palomino Laboratories Inc. in?

Palomino Laboratories Inc. (PALX) operates in the Semiconductors & Related Devices industry.

What exchange does PALX trade on?

Palomino Laboratories Inc. (PALX) trades on the OTC.

Where is Palomino Laboratories Inc. incorporated?

Palomino Laboratories Inc. is incorporated in DE.

When was Palomino Laboratories Inc. (PALX)'s most recent SEC filing?

Palomino Laboratories Inc. (PALX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.

What is PALX's EPS (earnings per share)?

Palomino Laboratories Inc. (PALX)'s trailing twelve month EPS is $-0.24 as of 2026-06-30.

What is PALX's ROE (return on equity)?

Palomino Laboratories Inc. (PALX)'s trailing twelve month Return on Equity (ROE) is -51.45% as of 2026-06-30.

What is PALX's ROA (return on assets)?

Palomino Laboratories Inc. (PALX)'s trailing twelve month Return on Assets (ROA) is -49.19% as of 2026-06-30.

What is PALX's ROIC (return on invested capital)?

Palomino Laboratories Inc. (PALX)'s trailing twelve month Return on Invested Capital (ROIC) is -66.91% as of 2025-12-31.

Wall Street's data.
Main Street's price.